Literature DB >> 9199328

Interdigitated residues within a small region of VP16 interact with Oct-1, HCF, and DNA.

J S Lai1, W Herr.   

Abstract

Upon infection, the herpes simplex virus (HSV) activator of immediate-early (IE) gene transcription VP16 forms a multiprotein-DNA complex with two cellular proteins, Oct-1 and HCF. First, VP16 associates with HCF independently of DNA, and this association stimulates subsequent association with Oct-1 on the DNA target of VP16 activation, the TAATGARAT motif found in HSV IE promoters. We have analyzed the involvement of VP16 residues lying near the carboxy-terminal transcriptional activation domain of VP16 in associating with HCF, Oct-1, and DNA. To assay VP16 association with HCF, we developed an electrophoretic mobility retardation assay in which HCF is used to retard the mobility of a hybrid VP16-GAL4 DNA-binding domain fusion protein bound to a GAL4 DNA-binding site. Analysis of an extensive set of individual and combined alanine substitutions over a 61-amino-acid region of VP16 shows that, even within a region as small as 13 amino acids, there are separate residues involved in association with either HCF, DNA, or Oct-1 bound to DNA; indeed, of two immediately adjacent amino acids in VP16, one is important for DNA binding and the other is important for HCF binding. These results suggest that a small region in VP16 is important for linking in close juxtaposition the four components of the VP16-induced complex and support the hypothesis that the structure of the Oct-1-VP16 interaction in this complex is similar to that formed by the yeast transcriptional regulatory proteins MATa1 and MAT alpha2. We propose that HCF stabilizes this Oct-1-VP16 interaction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199328      PMCID: PMC232246          DOI: 10.1128/MCB.17.7.3937

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

2.  A cellular factor binds to the herpes simplex virus type 1 transactivator Vmw65 and is required for Vmw65-dependent protein-DNA complex assembly with Oct-1.

Authors:  P Xiao; J P Capone
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

3.  Interference with the assembly of a virus-host transcription complex by peptide competition.

Authors:  A Haigh; R Greaves; P O'Hare
Journal:  Nature       Date:  1990-03-15       Impact factor: 49.962

4.  Separation of requirements for protein-DNA complex assembly from those for functional activity in the herpes simplex virus regulatory protein Vmw65.

Authors:  R Greaves; P O'Hare
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

5.  Cassettes of the f1 intergenic region.

Authors:  J Heitman; J Treisman; N G Davis; M Russel
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

6.  Activation of the U2 snRNA promoter by the octamer motif defines a new class of RNA polymerase II enhancer elements.

Authors:  M Tanaka; U Grossniklaus; W Herr; N Hernandez
Journal:  Genes Dev       Date:  1988-12       Impact factor: 11.361

7.  Characterization of a cellular factor which interacts functionally with Oct-1 in the assembly of a multicomponent transcription complex.

Authors:  M Katan; A Haigh; C P Verrijzer; P C van der Vliet; P O'Hare
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

8.  Structural requirements in the herpes simplex virus type 1 transactivator Vmw65 for interaction with the cellular octamer-binding protein and target TAATGARAT sequences.

Authors:  R F Greaves; P O'Hare
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

9.  The C-terminal 79 amino acids of the herpes simplex virus regulatory protein, Vmw65, efficiently activate transcription in yeast and mammalian cells in chimeric DNA-binding proteins.

Authors:  D J Cousens; R Greaves; C R Goding; P O'Hare
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

10.  The octamer-binding proteins form multi-protein--DNA complexes with the HSV alpha TIF regulatory protein.

Authors:  T M Kristie; J H LeBowitz; P A Sharp
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  30 in total

1.  A trans-acting peptide activates the yeast a1 repressor by raising its DNA-binding affinity.

Authors:  M R Stark; D Escher; A D Johnson
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Differences in determinants required for complex formation and transactivation in related VP16 proteins.

Authors:  M Grapes; P O'Hare
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency.

Authors:  Richard L Thompson; Nancy M Sawtell
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

4.  Analysis of the interaction between the essential herpes simplex virus 1 tegument proteins VP16 and VP1/2.

Authors:  Stanislava Svobodova; Susanne Bell; Colin M Crump
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

5.  HCF-dependent nuclear import of VP16.

Authors:  S La Boissière; T Hughes; P O'Hare
Journal:  EMBO J       Date:  1999-01-15       Impact factor: 11.598

6.  Phosphorylation of the VP16 transcriptional activator protein during herpes simplex virus infection and mutational analysis of putative phosphorylation sites.

Authors:  Søren Ottosen; Francisco J Herrera; James R Doroghazi; Angela Hull; Sheenu Mittal; William S Lane; Steven J Triezenberg
Journal:  Virology       Date:  2005-11-17       Impact factor: 3.616

Review 7.  A multiplicity of mediators: alternative forms of transcription complexes communicate with transcriptional regulators.

Authors:  M Chang; J A Jaehning
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

8.  VP16 targets an amino-terminal domain of HCF involved in cell cycle progression.

Authors:  A C Wilson; R N Freiman; H Goto; T Nishimoto; W Herr
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

9.  Interaction of HCF-1 with a cellular nuclear export factor.

Authors:  Shahana S Mahajan; Markus M Little; Rafael Vazquez; Angus C Wilson
Journal:  J Biol Chem       Date:  2002-09-15       Impact factor: 5.157

10.  Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo.

Authors:  Xibing Che; Leigh Zerboni; Marvin H Sommer; Ann M Arvin
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.